These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9865328)

  • 21. Development of a novel drug for transplantation: current results and future perspectives.
    Schorlemmer HU
    Transplant Proc; 2001 May; 33(3):2425-8. PubMed ID: 11377581
    [No Abstract]   [Full Text] [Related]  

  • 22. Putative pemphigus-like reaction to oral fluralaner in a dog.
    Dalmau A; Ordeix L
    Vet Dermatol; 2024 Aug; 35(4):441-445. PubMed ID: 38356040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis.
    Bohanec Grabar P; Grabnar I; Rozman B; Logar D; Tomsic M; Suput D; Trdan T; Peterlin Masic L; Mrhar A; Dolzan V
    Drug Metab Dispos; 2009 Oct; 37(10):2061-8. PubMed ID: 19581389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood distribution and single-dose pharmacokinetics of leflunomide.
    Lucien J; Dias VC; LeGatt DF; Yatscoff RW
    Ther Drug Monit; 1995 Oct; 17(5):454-9. PubMed ID: 8585107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leflunomide and malononitrilamides.
    Silva Júnior HT; Morris RE
    Am J Med Sci; 1997 May; 313(5):289-301. PubMed ID: 9145039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leflunomide in dermatology.
    Boyd AS
    J Am Acad Dermatol; 2012 Apr; 66(4):673-9. PubMed ID: 21962758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leflunomide. Arava, HWA 486, SU 101.
    Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of leflunomide in the treatment of rheumatoid arthritis: an experimental and clinical review.
    Schattenkirchner M
    Immunopharmacology; 2000 May; 47(2-3):291-8. PubMed ID: 10878295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of leflunomide on immune responses and models of inflammation.
    Bartlett RR; Anagnostopulos H; Zielinski T; Mattar T; Schleyerbach R
    Springer Semin Immunopathol; 1993; 14(4):381-94. PubMed ID: 8322168
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds.
    Tani A; Seno T; Yokoyama N; Nakagawa T; Tomiyasu H; Goto-Koshino Y; Tsujimoto H; Ohno K
    J Vet Med Sci; 2020 Apr; 82(4):437-440. PubMed ID: 32062634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 32. Leflunomide use in renal transplantation.
    Leca N
    Curr Opin Organ Transplant; 2009 Aug; 14(4):370-4. PubMed ID: 19512928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early clinical experience with leflunomide in uveitis.
    Roy M
    Can J Ophthalmol; 2007 Aug; 42(4):634. PubMed ID: 17641721
    [No Abstract]   [Full Text] [Related]  

  • 34. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB
    Orthop Nurs; 2003; 22(1):48-51. PubMed ID: 12640952
    [No Abstract]   [Full Text] [Related]  

  • 36. An unusual overdose of leflunomide in a patient with rheumatoid arthritis.
    Kamali S; Kasapoglu E; Uysal M; Inanc M; Gul A
    Ann Pharmacother; 2004; 38(7-8):1320-1. PubMed ID: 15138298
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppression--an overview.
    Miller E
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):144-9. PubMed ID: 9283237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients.
    Kraan MC; de Koster BM; Elferink JG; Post WJ; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Jul; 43(7):1488-95. PubMed ID: 10902750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of A77 1726 and leflunomide in domestic cats.
    Mehl ML; Tell L; Kyles AE; Chen YJ; Craigmill A; Gregory CR
    J Vet Pharmacol Ther; 2012 Apr; 35(2):139-46. PubMed ID: 21615755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
    Fragoso YD; Brooks JB
    Expert Rev Clin Pharmacol; 2015 May; 8(3):315-20. PubMed ID: 25712857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.